^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Follicular Lymphoma |
| Drug: | Ukoniq (umbralisib) (PI3Kδ inhibitor, Casein kinase I epsilon inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
02/05/2021
Excerpt:
UKONIQ is a kinase inhibitor indicated for the treatment of adult patients with...Relapsed or refractory follicular lymphoma (FL) who have received at least three prior lines of systemic therapy.
